Aldeyra Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. ALDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

23,858

Value ($000)

124

Weight

0.0%

2019 Q4 - 2025 Q4 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	124	0.0%	23,858	12/31/2025
2023 Q2	8/10/2023	1,420	0.0%	169,306	6/30/2023
2023 Q1	5/10/2023	1,818	0.0%	183,070	3/31/2023
2022 Q4	2/10/2023	1,287	0.0%	184,894	12/31/2022
2022 Q3	11/10/2022	1,208	0.0%	226,197	9/30/2022
2022 Q2	8/5/2022	271	0.0%	67,914	6/30/2022
2020 Q2	8/13/2020	68	0.0%	16,346	6/30/2020
2020 Q1	5/13/2020	246	0.0%	99,722	3/31/2020
2019 Q4	2/12/2020	520	0.0%	89,497	12/31/2019